0.962

1.27% 0.0121

After Hours: .98 0.018 +1.87%

Standard Biotools Inc (LAB)

Overview News Price History Option Chain Financials Discussions Forecast

Standard Biotools Inc stock is traded at $0.962, with a volume of 1.23M. It is up +1.27% in the last 24 hours and down -17.78% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Previous Close:

$0.9499

Open:

$0.955

24h Volume:

1.23M

Relative Volume:

0.66

Market Cap:

$375.25M

Revenue:

$105.90M

Net Income/Loss:

$-61.49M

P/E Ratio:

-4.8783

EPS:

-0.1972

Net Cash Flow:

$-82.65M

1W Performance:

-0.31%

1M Performance:

-17.78%

6M Performance:

-25.43%

1Y Performance:

-17.07%

1-Day Range:

$0.9457

$0.9832

1-Week Range:

$0.9418

$1.01

52-Week Range:

$0.92

$1.72

Standard Biotools Inc Stock (LAB) Company Profile

Name

Standard Biotools Inc

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

(650) 266-6000

Address

50 MILK STREET, BOSTON

Employee

389

Twitter

Next Earnings Date

2025-02-14

Latest SEC Filings

LAB's Discussions on Twitter

Compare LAB vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LAB Standard Biotools Inc	0.962	370.53M	105.90M	-61.49M	-82.65M	-0.1972
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-25	Downgrade	TD Cowen	Buy → Hold
Feb-27-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-16-24	Initiated	TD Cowen	Buy
Apr-04-24	Initiated	Jefferies	Buy
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Stock (LAB) Latest News

Mar 25, 2026

Downgrade Watch: Will Standard BioTools Inc stock hit new highs in YEAR2026 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn

Mar 25, 2026

Mar 22, 2026

Analysis Recap: Is Standard BioTools Inc impacted by rising rates2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Earnings Risk: Is Standard BioTools Inc impacted by rising rates2026 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 21, 2026

Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Mar 21, 2026

Pullback Watch: Does Standard BioTools Inc have declining or rising EPSMarket Sentiment Summary & Weekly Return Optimization Plans - baoquankhu1.vn

Mar 21, 2026

Mar 18, 2026

Whale Trades: Can Standard BioTools Inc stock double in the next yearGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Long Focus Capital Management LLC Acquires 1,292,804 Shares of Standard BioTools Inc. $LAB - MarketBeat

Mar 17, 2026